PRP for Meniscus Tears
Explore how PRP injections can treat meniscus tears. Learn about platelet-rich plasma therapy benefits, recovery, and results for meniscus tears.
Meniscus tears are among the most common knee injuries, and among the most controversial for PRP use. The evidence picture is specific: virtually all available clinical research examines PRP as an adjunct to meniscal repair surgery, not as a stand-alone injection therapy. Three systematic reviews published between 2024 and 2025, covering up to 354 patients, consistently show that PRP augmentation during meniscal repair reduces re-tear and failure rates, but does not improve patient-reported outcome scores compared to repair alone. Conservative intra-articular PRP injection for meniscus tears, without surgery, has essentially no high-quality trial evidence. This distinction matters for patients and clinicians considering PRP.
What Is a Meniscus Tear?
The menisci are two C-shaped wedges of fibrocartilage, the medial meniscus on the inner side of the knee and the lateral meniscus on the outer side, that sit between the femoral condyles and the tibial plateau. They function as shock absorbers, distribute compressive load across the joint surface, provide joint stability, and contribute to lubrication and nutrition of the articular cartilage. Each meniscus has an outer (peripheral) zone with a blood supply and an inner (avascular) zone that receives nutrition through diffusion.
Meniscus tears occur in two distinct patterns with different clinical implications. Acute traumatic tears, typically from a twisting or pivoting injury, most often occur in young athletes and frequently involve the vascular outer third of the meniscus, where healing is possible with surgical repair. Degenerative tears, the more common type in adults over 35, involve gradual deterioration of the meniscal tissue without a single precipitating event, often in the context of early knee osteoarthritis, and occur in the avascular inner zone where biological healing is limited.
Symptoms include medial or lateral joint line pain, swelling, catching, locking, and pain with squatting or twisting. Treatment depends on tear type, location, patient age, activity level, and associated injuries. Acute repairable tears in appropriate candidates are treated with meniscal repair surgery. Degenerative tears are typically managed conservatively with physical therapy, NSAIDs, and intra-articular injections. Total meniscectomy, once common, has been largely abandoned due to its strong association with accelerated knee osteoarthritis.
Imaging, typically MRI, is essential for characterizing tear morphology, location within the meniscus, and the presence of associated pathology such as knee osteoarthritis or ACL injury. These factors directly determine whether PRP is most applicable as a surgical augment or conservative injection.
How PRP Is Used for Meniscus Tears
PRP has been investigated in two distinct contexts for meniscus tears. First, as a surgical augment: PRP is applied to the repair site during arthroscopic meniscal repair, delivered as a clot, gel, or concentrated injection at the tear site, to enhance the biological environment for healing. This is where the available research is concentrated. Second, as a conservative injection: intra-articular PRP injection into the knee joint, without surgery, for patients managing a meniscus tear non-operatively. This application has essentially no dedicated high-quality clinical trial evidence.
The biological rationale for PRP as a surgical augment is strong: the platelet growth factors, PDGF, TGF-β, IGF-1, and VEGF, promote angiogenesis, stimulate fibrochondrocyte proliferation, and support collagen matrix production at the repair site. The inner zone of the meniscus is avascular and heals poorly; PRP theoretically bridges this limitation by delivering concentrated growth factors directly to the repair interface. The rationale for conservative intra-articular PRP is weaker: the injection reaches the joint environment but may have limited direct access to the torn meniscal tissue, particularly in the avascular zone.
What the Research Shows
The evidence base consists of three systematic reviews examining PRP as an adjunct to meniscal repair surgery. All three are consistent: PRP reduces structural failure rates but does not improve patient-reported outcome scores.
A 2025 systematic review and meta-analysis of 8 studies involving 354 patients examining PRP augmentation during meniscal repair1, published in the Journal of Orthopaedics, found that PRP significantly reduced meniscal re-tear and failure rates (18.2% vs 30.5%, p=0.019). However, no statistically significant difference was found between PRP and control groups on any patient-reported outcome measure, including Lysholm scores, VAS pain scores, IKDC scores, or WOMAC scores. The authors concluded PRP augmentation reduces structural failure but does not translate into improved clinical outcomes at the time points measured.
A 2024 systematic review and meta-analysis examining PRP augmentation for meniscal repair2, published in Arthroscopy: Sports Medicine and Rehabilitation, reached the same conclusion: PRP was associated with lower failure rates and lower VAS pain scores compared to control, but functional outcomes were mixed across included studies. The authors noted heterogeneity in PRP preparation methods and surgical techniques as limitations affecting interpretation.
A 2024 systematic review of randomized controlled trials of PRP for meniscal repair involving 139 patients3, published in the Journal of Orthopaedics and Traumatology, found mixed results on both MRI-based healing assessments and clinical outcome measures. While some studies showed improved healing signals on imaging, clinical outcome differences were inconsistent.
The honest summary: for PRP as a surgical augment during meniscal repair, the consistent finding across all three reviews is reduced structural failure rates with no improvement in patient-reported outcomes. For conservative intra-articular PRP without surgery, there is essentially no high-quality randomized trial evidence. Patients should understand which application is being proposed and that the existing evidence applies primarily to the surgical augment context.
PRP as Surgical Augment vs. Conservative Injection
When PRP is applied during meniscal repair surgery, it is placed directly at the tear site under direct arthroscopic visualization, either as a fibrin clot, a gel matrix, or an injected concentrate at the repair interface. This approach has the advantage of precise delivery to the target tissue, co-application with the mechanical repair, and a controlled biological environment optimized for healing. The evidence, while limited, consistently supports a reduction in structural failure rates.
Conservative intra-articular PRP, injected into the knee joint without surgery, has a different and weaker rationale for meniscus tears specifically. The growth factors diffuse through the joint environment and may reach the tear margins, but delivery is less targeted than surgical application, particularly for inner-zone avascular tears. This approach is used clinically for patients who are not surgical candidates or who are managing degenerative tears non-operatively, but should be understood as extrapolation from the surgical augment evidence base rather than independently validated practice.
Who Is a Good Candidate?
PRP augmentation during meniscal repair is most relevant for patients undergoing arthroscopic repair of acute or chronic repairable tears, particularly those involving the vascular outer zone or partial inner-zone tears in young active patients. The evidence supports its use as a biological adjunct to reduce re-tear risk, though patients should understand it does not improve clinical outcome scores beyond repair alone.
Conservative intra-articular PRP may be considered for patients with degenerative meniscus tears who are not surgical candidates, who have failed physical therapy and cortisone, and who want a biologic injection option before further surgical evaluation. These patients should understand this application has no high-quality dedicated RCT evidence. Patients with associated knee osteoarthritis may derive some joint-level benefit from intra-articular PRP, but the meniscal tear specifically is not the validated target.
Patients with locked knees, displaced bucket-handle tears, or complete meniscal root tears requiring urgent surgical intervention are not candidates for conservative injection management. Septic arthritis, clotting disorders, and active inflammatory arthropathy are contraindications to PRP.
What to Expect
When PRP is applied as a surgical augment, it is administered intraoperatively during arthroscopic meniscal repair. Recovery follows the standard meniscal repair protocol, typically 4–6 weeks non-weight-bearing, followed by progressive rehabilitation. No separate post-operative injection is required.
When PRP is administered as a conservative intra-articular knee injection, it is performed as an outpatient procedure under ultrasound guidance. Expect 2–5 days of increased knee soreness. Light activity is typically permitted within 1–2 days. Meaningful improvement, if it occurs, begins at 4–8 weeks. Physical therapy targeting quadriceps strengthening, hip stability, and movement pattern correction should run concurrently.
Explore related knee conditions treated with PRP, including knee osteoarthritis and patellar tendinitis, or find a specialist in the OrthopedicPRP provider directory.
Sources
1. Dave U, et al. Platelet-Rich Plasma Augmentation in Meniscal Repair: A Systematic Review and Meta-Analysis. J Orthop. 2025;73:62-71. PMID: 41487690.
2. Sakti M, et al. Efficacy of Platelet-Rich Plasma Augmentation in Meniscal Repair: A Systematic Review and Meta-Analysis. Arthrosc Sports Med Rehabil. 2024;6(4):100934. PMID: 39421348.
3. Utrilla GS, et al. Platelet-Rich Plasma in Meniscal Repair: A Systematic Review of Randomized Controlled Trials. J Orthop Traumatol. 2024;25(1):63. PMID: 39694969.
This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.
| Application | Injection Target | Evidence Level | Typical Protocol | Best Candidates |
|---|---|---|---|---|
| Meniscus Tear, Surgical Augment | Applied at repair site intraoperatively during arthroscopic meniscal repair | Limited-Moderate (2025 SR/MA 8 studies 354 patients, reduced failure rate 18.2% vs 30.5%; no PRO improvement; 2024 SR/MA, same; 2024 SR of RCTs, mixed) | Single intraoperative application by surgeon during meniscal repair | Acute/chronic repairable tears; vascular zone tears; young active patients; surgical candidates where added biologic augment is desired |
| Meniscus Tear, Conservative Intra-Articular Injection | Knee joint space under ultrasound guidance (non-surgical) | Very Limited (no dedicated high-quality RCTs; evidence extrapolated from surgical augment literature and knee OA PRP research) | 1 injection; reassess at 6–8 weeks | Degenerative tears not appropriate for surgery; failed PT and cortisone; not surgical candidates; full understanding of evidence gap required |
Frequently Asked Questions
Find a Meniscus Tear PRP Specialist Near You
Browse our directory of verified providers who offer PRP for meniscus tears and other knee conditions.
Search ProvidersOther Conditions
PRP for Achilles Tendinitis
Explore how PRP injections can treat achilles tendinitis. Learn about platelet-rich plasma therapy benefits, recovery, and results for achilles tendinitis.
PRP for ACL Injuries
Explore how PRP injections can treat acl injuries. Learn about platelet-rich plasma therapy benefits, recovery, and results for acl injuries.
PRP for Ankle Sprains
Explore how PRP injections can treat ankle sprains. Learn about platelet-rich plasma therapy benefits, recovery, and results for ankle sprains.
PRP for Carpal Tunnel Syndrome
Explore how PRP injections can treat carpal tunnel syndrome. Learn about platelet-rich plasma therapy benefits, recovery, and results for carpal tunnel syndr...
PRP for Chronic Low Back Pain
Explore how PRP injections can treat chronic low back pain. Learn about platelet-rich plasma therapy benefits, recovery, and results for chronic low back pain.
PRP for De Quervain's Tenosynovitis
Explore how PRP injections can treat de quervain's tenosynovitis. Learn about platelet-rich plasma therapy benefits, recovery, and results for de quervain's ...
PRP for Disc Degeneration
Explore how PRP injections can treat disc degeneration. Learn about platelet-rich plasma therapy benefits, recovery, and results for disc degeneration.
PRP for Elbow Bursitis
Explore how PRP injections can treat elbow bursitis. Learn about platelet-rich plasma therapy benefits, recovery, and results for elbow bursitis.
PRP for Facet Joint Syndrome
Explore how PRP injections can treat facet joint syndrome. Learn about platelet-rich plasma therapy benefits, recovery, and results for facet joint syndrome.
PRP for Frozen Shoulder
Explore how PRP injections can treat frozen shoulder. Learn about platelet-rich plasma therapy benefits, recovery, and results for frozen shoulder.